Gibbs Thomas Edward 4
4 · OptiNose, Inc. · Filed Mar 6, 2019
Insider Transaction Report
Form 4
OptiNose, Inc.OPTN
Gibbs Thomas Edward
Chief Commercial Officer
Transactions
- Award
Stock Option (Right to Buy)
2019-02-28+82,500→ 82,500 totalExercise: $7.42Exp: 2029-02-28→ Common Stock (82,500 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable over a four-year period commencing on February 28, 2019. Twenty-five percent (25%) of the option vests and becomes exercisable on February 28, 2020, and the balance vests in equal monthly installments (rounded down to the nearest whole share) over the remaining three years of the four-year period, subject to continued service with the Issuer.